PUBLISHER: The Business Research Company | PRODUCT CODE: 1889364
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889364
Docosahexaenoic acid (DHA) supplements are specialized dietary products that provide DHA, a vital omega-3 fatty acid crucial for optimal brain, eye, and heart health. These supplements are widely used by people of all ages, including pregnant women, infants, and adults, to support cognitive development, maintain overall wellness, and address dietary deficiencies in omega-3s.
The key types of docosahexaenoic acid (DHA) supplements are fatty acids, phospholipids, seafood fats and oils, and others. Fatty acids are organic compounds that act as the essential building blocks of lipids and provide vital nutrients. Available product forms include capsules, softgels, gummies, powders, and others and are sourced from fish oil, algal oil, krill oil, and others. These are distributed through online stores, supermarkets or hypermarkets, specialty stores, and others and are primarily used in applications including infant formula, dietary supplements, functional food and beverages, pharmaceuticals, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The docosahexaenoic acid (DHA) supplements market research report is one of a series of new reports from The Business Research Company that provides docosahexaenoic acid (DHA) supplements market statistics, including docosahexaenoic acid (DHA) supplements industry global market size, regional shares, competitors with a docosahexaenoic acid (DHA) supplements market share, detailed docosahexaenoic acid (DHA) supplements market segments, market trends and opportunities, and any further data you may need to thrive in the docosahexaenoic acid (DHA) supplements industry. This docosahexaenoic acid (DHA) supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The docosahexaenoic acid (DHA) supplements market size has grown rapidly in recent years. It will grow from $1.92 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be linked to increasing online and digital distribution channels, growing middle-class incomes in emerging markets, increasing demand for clean-label and allergen-free products, a rising ageing population, and increasing premiumization of supplement products.
The docosahexaenoic acid (DHA) supplements market size is expected to see rapid growth in the next few years. It will grow to $3.12 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be driven by rising health consciousness among consumers, growing lifestyle-related disorders driving preventive use, expansion of the infant and maternal nutrition segment, increasing fortified functional foods and beverages, and rising adoption of vegan or vegetarian diets. Major trends in the forecast period include advancement in extraction technologies, advancement in micro-encapsulation and nano-delivery systems, advancement in formulation innovation, advancement in supply-chain traceability and transparency technologies, and advancement in personalized nutrition and digital health platforms.
The growing adoption of dietary supplements is expected to drive the growth of the docosahexaenoic acid (DHA) supplements market. Dietary supplements, which contain vitamins, minerals, herbs, or other nutrients, are designed to enhance nutrition and support overall well-being. The rising awareness of health and wellness has led more consumers to seek additional nutrients that promote disease prevention and balanced nutrition. DHA supplements, in particular, have gained popularity for their ability to fill nutritional gaps, support cognitive development, enhance cardiovascular health, and improve overall wellness. For instance, in September 2025, the Australian Bureau of Statistics reported that around 33.6% of individuals aged 2 years and older-approximately 8.5 million people-used dietary supplements in 2023, a 17% increase from 2022. This growing adoption of dietary supplements is a key factor driving the expansion of the DHA supplements market.
Companies in the DHA supplements market are innovating with new products, such as algal oil-derived polyunsaturated fatty acid (PUFA) supplements, which offer improved bioavailability, sustainability, and health benefits targeted to consumers. Algal oil-derived PUFA supplements are nutrient-rich products sourced from algae, providing high levels of omega-3 fatty acids, particularly DHA, which support cognitive function, cardiovascular health, and overall well-being. For example, in December 2024, Nature's Bounty, a U.S.-based dietary supplements company, launched a plant-based omega-3 supplement as a vegetarian alternative to traditional fish oil. Just one softgel provides 520 mg of omega-3s, including EPA and DHA, supporting heart, joint, and skin health. This plant-based option is sustainably produced, odorless, and ideal for those seeking plant-based wellness with benefits for circulation, energy metabolism, and cardiovascular support.
In October 2024, KD Pharma Group SA, a Switzerland-based pharmaceutical company, acquired DSM-Firmenich's Marine Lipids business for an undisclosed amount. This acquisition positions KD Pharma as the world's largest omega-3 manufacturer, enabling it to expand its leadership across the entire omega-3 value chain, strengthen global production and distribution capabilities, and diversify its product offerings in the food, dietary supplement, and pharmaceutical sectors. DSM-Firmenich's Marine Lipids business specializes in providing DHA supplements and complements KD Pharma's strategic goals in the omega-3 market.
Major companies operating in the docosahexaenoic acid (dha) supplements market are Archer Daniels Midland Company, BASF SE, Stepan Company, Corbion N.V., Pharmavite LLC, Neptune Wellness Solutions Inc., NOW Foods, Bioplus Life Sciences Private Limited, KD Pharma Group SA, Nordic Naturals Inc., Clover Corporation Limited, Arjuna Natural Extracts Ltd., Aker BioMarine AS, Source Omega LLC, Epax Norway AS, Jiangsu Auqi Marine Biotechnology Co. Ltd., Navchetana Kendra Health Care Private Limited, Novotech Nutraceuticals Inc., AlgalR NutraPharms, Koninklijke DSM N.V., Huve Nutraceuticals Ltd.
North America was the largest region in the docosahexaenoic acid (DHA) supplements market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the docosahexaenoic acid (DHA) supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The docosahexaenoic acid (DHA) supplements market consists of sales of chewable tablets, nut butters enriched with docosahexaenoic acid, and ready-to-drink nutritional shakes or smoothies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Docosahexaenoic Acid (DHA) Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on docosahexaenoic acid (dha) supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for docosahexaenoic acid (dha) supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The docosahexaenoic acid (dha) supplements market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.